These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 19245711

  • 1. Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone.
    Sullivan SD, Alfonso-Cristancho R, Conner C, Hammer M, Blonde L.
    Cardiovasc Diabetol; 2009 Feb 26; 8():12. PubMed ID: 19245711
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US.
    Lee WC, Conner C, Hammer M.
    Curr Med Res Opin; 2011 May 26; 27(5):897-906. PubMed ID: 21348806
    [Abstract] [Full Text] [Related]

  • 3. A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus.
    Sullivan SD, Alfonso-Cristancho R, Conner C, Hammer M, Blonde L.
    Pharmacotherapy; 2009 Nov 26; 29(11):1280-8. PubMed ID: 19873688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus.
    Davies MJ, Chubb BD, Smith IC, Valentine WJ.
    Diabet Med; 2012 Mar 26; 29(3):313-20. PubMed ID: 21883438
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results.
    Jendle J, Torffvit O, Ridderstråle M, Ericsson Å, Nilsen B, Bøgelund M.
    J Med Econ; 2012 Mar 26; 15 Suppl 2():1-5. PubMed ID: 22853443
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of liraglutide in type II diabetes: a systematic review.
    Zueger PM, Schultz NM, Lee TA.
    Pharmacoeconomics; 2014 Nov 26; 32(11):1079-91. PubMed ID: 25052903
    [Abstract] [Full Text] [Related]

  • 9. Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China.
    Gao L, Zhao FL, Li SC.
    Int J Technol Assess Health Care; 2012 Oct 26; 28(4):436-44. PubMed ID: 23006540
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes.
    Horowitz M, Flint A, Jones KL, Hindsberger C, Rasmussen MF, Kapitza C, Doran S, Jax T, Zdravkovic M, Chapman IM.
    Diabetes Res Clin Pract; 2012 Aug 26; 97(2):258-66. PubMed ID: 22446097
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of liraglutide.
    Jeong KH, Yoo BK.
    Int J Clin Pharm; 2011 Oct 26; 33(5):740-9. PubMed ID: 21952951
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
    Hermansen K, Kolotkin RL, Hammer M, Zdravkovic M, Matthews D.
    Prim Care Diabetes; 2010 Jul 26; 4(2):113-7. PubMed ID: 20444662
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Liraglutide: a review of its use in type 2 diabetes mellitus.
    Croom KF, McCormack PL.
    Drugs; 2009 Oct 01; 69(14):1985-2004. PubMed ID: 19747013
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials.
    Fonseca VA, Devries JH, Henry RR, Donsmark M, Thomsen HF, Plutzky J.
    J Diabetes Complications; 2014 Oct 01; 28(3):399-405. PubMed ID: 24561125
    [Abstract] [Full Text] [Related]

  • 20. [Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)].
    García-Hernández P, Arechavaleta-Granell Mdel R, Yamamoto J, Falahati A, González-Gálvez G, Grupo de Investigadores de LEAD-3 en México.
    Rev Med Inst Mex Seguro Soc; 2010 Oct 01; 48(5):543-8. PubMed ID: 21205505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.